Used as a chiral intermediate in the synthesis of pharmaceuticals, particularly in the development of central nervous system (CNS) agents. Its (R)-enantiomeric structure, along with the 3-bromophenyl and 2,2,2-trifluoroethanamine moieties, supports the creation of enantiomerically pure compounds with enhanced blood-brain barrier penetration and metabolic stability, which are critical for drug efficacy and safety. Commonly employed in the preparation of antidepressants and antipsychotics due to its ability to influence neurotransmitter activity. The presence of bromine allows for further functionalization via cross-coupling reactions, enhancing its utility in medicinal chemistry.